For citations:
Kolbin A.S., Vilum I.A., Proskurin М.A., Balykina Yu.E. PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMPACT ANALYSIS. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2017;10(1):39-45. (In Russ.) https://doi.org/10.17749/2070-4909.2017.10.1.039-045

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.